|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 94.92 USD | -3.79% |
|
-0.82% | -7.07% |
Company Valuation: Guardant Health, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 10,168 | 2,786 | 3,283 | 3,775 | 13,160 | 12,586 | - | - |
| Change | - | -72.6% | 17.84% | 14.96% | 248.64% | -4.36% | - | - |
| Enterprise Value (EV) 1 | 10,370 | 2,912 | 3,255 | 4,077 | 13,462 | 13,047 | 12,946 | 12,701 |
| Change | - | -71.91% | 11.75% | 25.27% | 230.18% | -3.08% | -0.77% | -1.89% |
| P/E ratio | -25x | -4.24x | -6.32x | -8.58x | -30.8x | -32.5x | -43.6x | -149x |
| PBR | 15.8x | 46.4x | 20.7x | -27.1x | -134x | -58.2x | 111x | 26.7x |
| PEG | - | -0.1x | 0.2x | 0.5x | 4.57x | 2.7x | 1.7x | 2.1x |
| Capitalization / Revenue | 27.2x | 6.2x | 5.82x | 5.11x | 13.4x | 9.6x | 7.47x | 5.84x |
| EV / Revenue | 27.8x | 6.48x | 5.77x | 5.52x | 13.7x | 9.95x | 7.68x | 5.89x |
| EV / EBITDA | -26.7x | -5.84x | -7.46x | -10.2x | -61x | -71.8x | -405x | 56x |
| EV / EBIT | -25.2x | -5.35x | -5.76x | -9.19x | -30.8x | -36.3x | -52.1x | -261x |
| EV / FCF | -36.5x | -7.53x | -9.42x | -14.8x | -57.8x | -68.3x | -202x | 86.2x |
| FCF Yield | -2.74% | -13.3% | -10.6% | -6.74% | -1.73% | -1.47% | -0.5% | 1.16% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -4 | -6.41 | -4.28 | -3.56 | -3.32 | -2.918 | -2.175 | -0.6386 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 373.7 | 449.5 | 563.9 | 739 | 982 | 1,312 | 1,685 | 2,156 |
| EBITDA 1 | -388.7 | -498.9 | -436.3 | -399.5 | -220.8 | -181.7 | -31.99 | 226.8 |
| EBIT 1 | -411 | -544.4 | -564.7 | -443.6 | -437.2 | -359.5 | -248.6 | -48.72 |
| Net income 1 | -405.7 | -654.6 | -479.4 | -436.4 | -416.3 | -381.2 | -263.2 | -71.46 |
| Net Debt 1 | 202.1 | 126.2 | -28.67 | 302.6 | 302.4 | 460.4 | 360.1 | 115 |
| Reference price 2 | 100.02 | 27.20 | 27.05 | 30.55 | 102.14 | 94.92 | 94.92 | 94.92 |
| Nbr of stocks (in thousands) | 101,656 | 102,436 | 121,380 | 123,555 | 128,839 | 132,600 | - | - |
| Announcement Date | 23/02/22 | 23/02/23 | 22/02/24 | 20/02/25 | 19/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| -32.53x | 9.95x | -71.69x | -.--% | 12.59B | ||
| 16.5x | 1.91x | 7.68x | 1.56% | 9.82B | ||
| 22.56x | 4x | 11.25x | - | 6.11B | ||
| 21.87x | 7.57x | 17.11x | 2.64% | 5.91B | ||
| 21.19x | 3.58x | 11.11x | 1.92% | 4.34B | ||
| 128.21x | 3.61x | 22.78x | -.--% | 4.11B | ||
| 16.86x | - | - | 3.8% | 2.82B | ||
| -26.06x | 3.6x | -29.87x | -.--% | 2.69B | ||
| Average | 21.07x | 4.89x | -4.52x | 1.42% | 6.05B | |
| Weighted average by Cap. | 12.74x | 5.56x | -13.07x | 1.18% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- GH Stock
- Valuation Guardant Health, Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















